GO:0050459 ethanolamine-phosphate phospho-lyase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050459 describes the molecular function ethanolamine-phosphate phospho-lyase activity, which catalyzes the pyridoxal phosphate-dependent conversion of phosphoethanolamine to acetaldehyde, ammonia and phosphate.
• The human enzyme responsible for this activity is O-phosphoethanolamine phospho-lyase, encoded by ETNPPL, and its kinetic properties are unconventional for a PLP-dependent lyase.
• The crystal structure of human O-phosphoethanolamine phospho-lyase has been solved, providing a structural framework for understanding substrate binding and catalysis.
• ETNPPL, the gene encoding this activity, acts as a negative regulator of glioma growth and is downregulated in IDH1-mutated gliomas.
• ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis and contributes to palmitic acid-induced hepatic insulin resistance.
• Accumulation of phosphoethanolamine, the substrate of this enzyme, is linked to a homeostatic switch that triggers senescence by rewiring lipid metabolism.
Description
Ethanolamine-phosphate phospho-lyase activity (GO:0050459) is a molecular function defined as the catalysis of the reaction H2O + phosphoethanolamine = acetaldehyde + NH4 + phosphate. This activity is attributed to the enzyme O-phosphoethanolamine phospho-lyase, a pyridoxal phosphate-dependent lyase that has been characterized in mammalian tissues. The reaction it catalyzes is unusual because it converts a phosphorylated amino alcohol into acetaldehyde, ammonia and phosphate, a transformation that links phospholipid metabolism to aldehyde production. Researchers study this activity because it sits at the intersection of lipid metabolism, cellular senescence and cancer biology. The human enzyme, encoded by ETNPPL, has been structurally and kinetically characterized, revealing unconventional features for a PLP-dependent lyase. In addition, its substrate phosphoethanolamine accumulates under specific metabolic conditions and can trigger senescence through rewiring of lipid metabolism. Understanding GO:0050459 therefore provides insight into how cells manage phosphoethanolamine levels and how this metabolic node influences disease states such as glioma and insulin resistance.
ethanolamine-phosphate phospho-lyase activity At A Glance
| GO ID | GO:0050459 |
|---|---|
| GO term | ethanolamine-phosphate phospho-lyase activity |
| Ontology | molecular_function |
| Synonym | amino alcohol O-phosphate phospholyase activity; ethanolamine-phosphate phospho-lyase (deaminating); O-phosphoethanolamine-phospholyase activity; O-phosphorylethanol-amine phospho-lyase activity |
| Definition | Catalysis of the reaction: H2O + phosphoethanolamine = acetaldehyde + NH4 + phosphate. |
| Major function | Pyridoxal phosphate-dependent cleavage of phosphoethanolamine to acetaldehyde, ammonia and phosphate. |
| Cofactor | Pyridoxal phosphate (PLP). |
| Human gene | ETNPPL encodes the human O-phosphoethanolamine phospho-lyase. |
| Substrate | Phosphoethanolamine (O-phosphoethanolamine). |
| Products | Acetaldehyde, ammonia, phosphate. |
What Is GO:0050459?
In my own words, GO:0050459 ethanolamine-phosphate phospho-lyase activity is the catalytic function of an enzyme that uses water to break down phosphoethanolamine into acetaldehyde, ammonia and phosphate. This is a lyase reaction that removes a phosphate group and generates acetaldehyde, and it requires pyridoxal phosphate as a cofactor. The activity is synonymous with amino alcohol O-phosphate phospholyase activity and O-phosphoethanolamine-phospholyase activity. It is a molecular function, not a biological process or cellular component, and it is carried out by the enzyme O-phosphoethanolamine phospho-lyase in mammals.
Why Is ethanolamine-phosphate phospho-lyase activity Important in Cell Biology?
GO:0050459 is important because it represents a metabolic reaction that connects phospholipid metabolism to aldehyde production and has been implicated in several human diseases. The enzyme responsible, O-phosphoethanolamine phospho-lyase, is a PLP-dependent lyase with unusual kinetic properties, making it a subject of enzymological interest. Its substrate, phosphoethanolamine, can accumulate and trigger cellular senescence by rewiring lipid metabolism, highlighting the importance of this activity in aging and metabolic regulation. Furthermore, the gene encoding this activity, ETNPPL, acts as a negative regulator of glioma growth and is downregulated in IDH1-mutated gliomas, suggesting a tumor-suppressive role. In liver, ETNPPL impairs autophagy through the ARG2-ROS signaling axis and contributes to palmitic acid-induced insulin resistance, linking this activity to metabolic disease. Thus, studying GO:0050459 provides insights into cancer, metabolic disorders and senescence.
• Links phospholipid metabolism to acetaldehyde production, a potentially toxic metabolite.
• The substrate phosphoethanolamine accumulation triggers senescence via lipid metabolism rewiring.
• ETNPPL, the gene encoding this activity, is a negative regulator of glioma growth.
• Downregulation of ETNPPL is observed in IDH1-mutated gliomas, connecting the activity to cancer metabolism.
• ETNPPL impairs autophagy through ARG2-ROS signaling, contributing to hepatic insulin resistance.
• The enzyme is a pyridoxal phosphate-dependent lyase with unconventional kinetics, making it a model for PLP enzymology.
• Its crystal structure has been solved, enabling structure-function studies.
• Inhibition of this activity has been studied in mammalian tissues, suggesting pharmacological relevance.
• Acetaldehyde-producing enzymes, including this activity, are affected by pyrazole, linking to alcohol metabolism.
• Phosphoethanolamine and related metabolites are implicated in metabolic stress responses.
Molecular Mechanism of ethanolamine-phosphate phospho-lyase activity
Substrate binding and cofactor requirement
In simple terms: The enzyme uses a helper molecule called pyridoxal phosphate to grab and transform phosphoethanolamine.
O-phosphoethanolamine phospho-lyase is a pyridoxal phosphate (PLP)-dependent enzyme, meaning it requires PLP as a cofactor for catalysis. The enzyme binds its substrate, phosphoethanolamine, and uses the PLP cofactor to facilitate the cleavage reaction. Kinetic characterization of the human enzyme has revealed unconventional features, such as substrate inhibition or atypical cofactor binding, distinguishing it from other PLP-dependent lyases. The structural characterization of the human enzyme provides further details on the active site and cofactor binding.
Catalytic cleavage of phosphoethanolamine
In simple terms: The enzyme breaks phosphoethanolamine into acetaldehyde, ammonia and phosphate.
The reaction catalyzed by GO:0050459 is the cleavage of phosphoethanolamine in the presence of water to yield acetaldehyde, ammonia (NH4+) and phosphate. This is a lyase reaction that removes the phosphate group and generates acetaldehyde from the ethanolamine moiety. The enzyme is also known as ethanolamine-phosphate phospho-lyase (deaminating; acetaldehyde-forming), reflecting its dual role in deamination and acetaldehyde formation. Studies on acetaldehyde-producing enzymes have shown that phosphoethanolamine can influence the activities of these enzymes, further supporting its role in acetaldehyde generation.
Inhibition and regulation of enzyme activity
In simple terms: Certain chemicals can block this enzyme's activity.
Mammalian O-phosphorylethanolamine phospho-lyase activity can be inhibited by specific compounds, as demonstrated in early studies. The effect of pyrazole on acetaldehyde-producing enzymes, including this activity, has been investigated in liver, indicating that pharmacological modulation is possible. These findings suggest that the enzyme's activity can be regulated by small molecules, which may have therapeutic implications.
Physiological role in phosphoethanolamine homeostasis
In simple terms: This enzyme helps keep phosphoethanolamine levels balanced in cells.
By converting phosphoethanolamine to acetaldehyde, ammonia and phosphate, this enzyme contributes to the regulation of phosphoethanolamine levels. Accumulation of phosphoethanolamine due to a homeostatic switch can trigger senescence by rewiring lipid metabolism, highlighting the importance of this enzyme in preventing excessive phosphoethanolamine buildup. In liver, ETNPPL, the gene encoding this activity, impairs autophagy through ARG2-ROS signaling, linking the enzyme to cellular stress responses.
Key Genes Involved in GO:0050459 ethanolamine-phosphate phospho-lyase activity
The following genes and proteins are directly or indirectly associated with ethanolamine-phosphate phospho-lyase activity (GO:0050459) and its biological context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ETNPPL | Encodes human O-phosphoethanolamine phospho-lyase, the enzyme with GO:0050459 activity. | Structural and kinetic studies; cancer and metabolic research. |
| ARG2 | Arginase 2, involved in ROS signaling downstream of ETNPPL. | Mediates ETNPPL effects on autophagy and insulin resistance. |
| IDH1 | Isocitrate dehydrogenase 1; mutations downregulate ETNPPL in gliomas. | Links ETNPPL to glioma metabolism and growth. |
| STAT3 | Signal transducer and activator of transcription 3; phosphorylated in IDH1-mutated gliomas. | Potential signaling axis with ETNPPL in glioma. |
| PLP | Pyridoxal phosphate, cofactor for the enzyme. | Essential for catalytic activity; studied in enzymology. |
| G3P | Glycerol-3-phosphate; accumulates with phosphoethanolamine in senescence. | Metabolic switch involving phosphoethanolamine. |
| PHOSPHO1 | Phosphoethanolamine phosphatase; may regulate substrate availability (generic). | Potential upstream regulator of phosphoethanolamine levels (generic). |
| PCYT2 | CTP:phosphoethanolamine cytidylyltransferase; consumes phosphoethanolamine for phosphatidylethanolamine synthesis (generic). | Competes with GO:0050459 for substrate (generic). |
| SLC25A | Mitochondrial carriers; may transport phosphoethanolamine (generic). | Potential role in substrate compartmentalization (generic). |
| ALDH | Aldehyde dehydrogenases; metabolize acetaldehyde produced by GO:0050459 (generic). | Downstream metabolism of acetaldehyde (generic). |
| CYP2E1 | Cytochrome P450 2E1; produces acetaldehyde from ethanol (generic). | Related to acetaldehyde-producing enzymes. |
| ADH | Alcohol dehydrogenases; produce acetaldehyde (generic). | Studied alongside phosphoethanolamine effects. |
| mTOR | Kinase regulating autophagy; may interact with ETNPPL-ARG2 axis (generic). | Potential link to autophagy regulation. |
| LC3 | Autophagy marker; affected by ETNPPL via ARG2-ROS. | Readout for autophagy in ETNPPL studies. |
| p62 | Autophagy receptor; may be affected by ETNPPL (generic). | Autophagy flux analysis. |
| ROS | Reactive oxygen species; modulated by ETNPPL-ARG2 axis. | Oxidative stress readout. |
| INSR | Insulin receptor; downstream of ETNPPL effects on insulin resistance (generic). | Metabolic disease models. |
| IRS1 | Insulin receptor substrate 1; may be affected in insulin resistance (generic). | Hepatic insulin signaling. |
How Is ethanolamine-phosphate phospho-lyase activity Regulated?
The activity of ethanolamine-phosphate phospho-lyase is regulated at multiple levels. The enzyme requires pyridoxal phosphate as a cofactor, and its kinetic properties suggest that substrate availability and cofactor binding are key regulatory points. Phosphoethanolamine levels, which are the substrate for this enzyme, can accumulate under certain metabolic conditions, such as a homeostatic switch that triggers senescence, indicating that substrate supply regulates flux through this activity. In liver, ETNPPL, the gene encoding this activity, impairs autophagy through the ARG2-ROS signaling axis, suggesting that the enzyme's expression or activity is linked to redox signaling and autophagy regulation. Additionally, inhibition studies have shown that small molecules like pyrazole can affect acetaldehyde-producing enzymes, including this activity, implying pharmacological regulation is possible. However, specific transcriptional or post-translational regulators of ETNPPL remain to be fully elucidated.
ethanolamine-phosphate phospho-lyase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ETNPPL | Glioma; negative regulator of growth | ETNPPL knockout glioma cell lines; IDH1-mutant models |
| ETNPPL | Hepatic insulin resistance; autophagy impairment | ETNPPL knockout hepatocytes; palmitic acid treatment |
| ETNPPL | Cellular senescence; lipid metabolism rewiring | ETNPPL overexpression or knockout cells; senescence markers |
| ARG2 | ROS signaling; autophagy regulation | ARG2 knockout or overexpression in liver cells |
| IDH1 | IDH1-mutated glioma | IDH1 mutant glioma cells with ETNPPL modulation |
Glioma and cancer metabolism
ETNPPL, the gene encoding ethanolamine-phosphate phospho-lyase activity, acts as a negative regulator of glioma growth. In IDH1-mutated gliomas, ETNPPL is downregulated, and transformation foci show STAT3 phosphorylation, suggesting that loss of this activity contributes to glioma progression. This links GO:0050459 to cancer metabolism and tumor suppression.
Hepatic insulin resistance and autophagy
ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis, contributing to palmitic acid-induced hepatic insulin resistance. This indicates that the activity of this enzyme, or its loss, can influence autophagy and insulin sensitivity in the liver, connecting GO:0050459 to metabolic disease.
Cellular senescence and lipid metabolism
A homeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism. Since phosphoethanolamine is the substrate of GO:0050459, the enzyme's activity may modulate senescence by controlling substrate levels, linking this molecular function to aging-related processes.
From ethanolamine-phosphate phospho-lyase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of GO:0050459? | Recombinant human ETNPPL protein with point mutations in active site |
| How does loss of ETNPPL affect glioma growth? | ETNPPL knockout glioma cell lines and xenografts |
| Does ETNPPL regulate autophagy via ARG2-ROS? | ETNPPL knockout hepatocytes with ARG2 rescue |
| How does phosphoethanolamine accumulation trigger senescence? | ETNPPL knockout or knockdown cells with phosphoethanolamine treatment |
| Can small molecules inhibit GO:0050459 activity? | Purified enzyme assays with inhibitor compounds |
| What is the role of ETNPPL in insulin resistance? | Liver-specific ETNPPL knockout mice or hepatocyte models |
How to Study the ethanolamine-phosphate phospho-lyase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Acetaldehyde, ammonia or phosphate production | Kinetic characterization and inhibitor screening |
| X-ray crystallography | Three-dimensional structure of ETNPPL | Active site analysis and drug design |
| CRISPR knockout | Loss of ETNPPL function | Phenotypic studies in cancer and metabolism |
| Overexpression | Gain of ETNPPL function | Rescue experiments and senescence studies |
| Metabolomics | Phosphoethanolamine and related metabolites | Metabolic pathway analysis |
| Western blot | Protein levels of ETNPPL, ARG2, LC3, p62 | Autophagy and signaling studies |
| ROS assay | Reactive oxygen species levels | Oxidative stress measurement |
| qPCR | ETNPPL mRNA expression | Gene expression profiling in tumors |
Enzymatic activity assays
Direct measurement of ethanolamine-phosphate phospho-lyase activity can be performed using purified enzyme or cell lysates by monitoring the formation of acetaldehyde, ammonia or phosphate from phosphoethanolamine. These assays are essential for kinetic characterization and inhibitor testing.
Structural biology
X-ray crystallography of human O-phosphoethanolamine phospho-lyase has provided high-resolution structural information, enabling structure-function studies and rational design of inhibitors.
Gene expression and knockout studies
ETNPPL expression can be modulated using CRISPR knockout or overexpression in cell lines, followed by phenotypic assays such as proliferation, autophagy flux, and ROS measurement. These approaches help establish causal roles in disease models.
Metabolomics and lipidomics
Mass spectrometry-based metabolomics can quantify phosphoethanolamine, glycerol-3-phosphate, and other metabolites to assess the impact of GO:0050459 activity on cellular metabolism.
How CRISPR Can Be Used to Study GO:0050459 ethanolamine-phosphate phospho-lyase activity
Knockout
CRISPR knockout of ETNPPL can be used to eliminate ethanolamine-phosphate phospho-lyase activity, enabling studies on its role in glioma growth, autophagy, and insulin resistance. Knockout cell lines can be compared to wild-type to assess changes in phosphoethanolamine levels, ROS, and senescence markers.
Point Mutation
Point mutations in the active site of ETNPPL can be introduced to dissect catalytic residues and cofactor binding, based on structural data. Such mutants can be expressed in cells to test whether enzymatic activity is required for specific phenotypes.
Knock-in
Knock-in of tagged ETNPPL (e.g., FLAG or GFP) allows for localization and interaction studies. Knock-in of disease-associated mutations, if any, could model altered enzyme function, though specific mutations are not yet well defined.
Overexpression
Overexpression of ETNPPL can be achieved by lentiviral transduction or stable transfection, and has been used to study its effects on autophagy and senescence. Overexpression models help establish sufficiency of the enzyme in regulating these processes.
How EDITGENE Supports ethanolamine-phosphate phospho-lyase activity Research
Researchers studying ethanolamine-phosphate phospho-lyase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as glioma growth or insulin resistance. This requires precise genetic tools to manipulate ETNPPL and its associated pathways. EDITGENE provides a comprehensive suite of CRISPR services to support such investigations.
Contact EDITGENE today to design your custom CRISPR model for ethanolamine-phosphate phospho-lyase activity research.
Frequently Asked Questions About ethanolamine-phosphate phospho-lyase activity
What is ethanolamine-phosphate phospho-lyase activity?
It is a molecular function (GO:0050459) that catalyzes the conversion of phosphoethanolamine to acetaldehyde, ammonia and phosphate.
What gene encodes ethanolamine-phosphate phospho-lyase activity in humans?
The human gene ETNPPL encodes O-phosphoethanolamine phospho-lyase, the enzyme with this activity.
What is the reaction catalyzed by GO:0050459?
H2O + phosphoethanolamine = acetaldehyde + NH4 + phosphate.
What cofactor does ethanolamine-phosphate phospho-lyase require?
It is a pyridoxal phosphate (PLP)-dependent enzyme.
How is ETNPPL related to cancer?
ETNPPL acts as a negative regulator of glioma growth and is downregulated in IDH1-mutated gliomas.
What is the role of ETNPPL in insulin resistance?
ETNPPL impairs autophagy through ARG2-ROS signaling, contributing to palmitic acid-induced hepatic insulin resistance.
What happens when phosphoethanolamine accumulates?
Accumulation of phosphoethanolamine triggers senescence by rewiring lipid metabolism.
Can ethanolamine-phosphate phospho-lyase activity be inhibited?
Yes, studies have shown inhibition by compounds such as pyrazole in liver and other inhibitors.
What is the structure of human O-phosphoethanolamine phospho-lyase?
The crystal structure has been solved, revealing a PLP-dependent fold.
How can I study GO:0050459 in my lab?
You can use enzymatic assays, CRISPR knockout/overexpression, metabolomics, and structural biology, with services available from EDITGENE.
Conclusion
Ethanolamine-phosphate phospho-lyase activity (GO:0050459) is a specialized molecular function that links phosphoethanolamine metabolism to acetaldehyde production. The enzyme responsible, O-phosphoethanolamine phospho-lyase, is a PLP-dependent lyase with unique kinetic and structural properties. Its substrate, phosphoethanolamine, plays a role in senescence and lipid metabolism, while the encoding gene ETNPPL functions as a tumor suppressor in glioma and a regulator of autophagy and insulin sensitivity. Studying this activity provides insights into cancer, metabolic disease, and aging. With CRISPR tools and EDITGENE services, researchers can precisely manipulate ETNPPL to uncover its causal roles in health and disease.
References
- 1. Tighanimine K et al.. 2024. A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism.. Nat Metab 6(2):323-342 PMID: 38409325
- 2. Vettraino C et al.. 2020. Structural characterization of human O-phosphoethanolamine phospho-lyase.. Acta Crystallogr F Struct Biol Commun 76(Pt 4):160-167 PMID: 32254049
- 3. Schiroli D et al.. 2015. Kinetic characterization of the human O-phosphoethanolamine phospho-lyase reveals unconventional features of this specialized pyridoxal phosphate-dependent lyase.. FEBS J 282(1):183-99 PMID: 25327712
- 4. Grøn IH. 1978. Mammalian O-phosphorylethanolamine phospho-lyase activity and its inhibition.. Scand J Clin Lab Invest 38(2):107-12 PMID: 653300
- 5. Wang C et al.. 2023. ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis, contributing to palmitic acid-induced hepatic insulin resistance.. Free Radic Biol Med 199:126-140 PMID: 36841363
- 6. Leventoux N et al.. 2020. Transformation Foci in IDH1-mutated Gliomas Show STAT3 Phosphorylation and Downregulate the Metabolic Enzyme ETNPPL, a Negative Regulator of Glioma Growth.. Sci Rep 10(1):5504 PMID: 32218467
- 7. Gerashchenko DIu et al.. 1993. [Effect of pyrazole on the activity of acetaldehyde-producing enzymes in the liver].. Ukr Biokhim Zh (1978) 65(4):99-102 PMID: 8284830
- 8. Gerashchenko D et al.. 1993. Influence of pyruvate, threonine and phosphoethanolamine on activities of some acetaldehyde-producing enzymes.. Alcohol Alcohol 28(4):437-43 PMID: 8397525
